Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Biotech Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (70)
ARTG (10)
Cancellation or suspension (3)

Date

2023 (3)
2020 (1)
2019 (42)
2018 (2)
2017 (27)
2016 (1)
2013 (1)
2012 (5)
1991 (1)

Results for "[search-keyword]"

Search

Sponsor content

83 result(s) found, displaying 41 to 50

WL-CAPTOPRIL 12.5 captopril 12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
WL-CAPTOPRIL 25 captopril 25mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
WL-CAPTOPRIL 50 captopril 50mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
BIOTECH INTERNATIONAL KAOLIN & OPIUM MIXTURE oral liquid bottle Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
GOLD CROSS METHYL SALICYLATE COMPOUND OINTMENT A.P.F. Ointment jar Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
WL-DILTIAZEM 60mg diltiazem hydrochloride tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
WL-GEMFIBROZIL 600 Gemfibrozil 600mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd
DAVID CRAIG PARACETAMOL 500mg and IBUPROFEN 200mg film coated tablet blister pack (285250)

6 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DAVID CRAIG PARACETAMOL 500mg and IBUPROFEN 200mg film coated tablet blister pack.
GOLD CROSS MINOXIDIL EXTRA STRENGTH 5% w/v topical application bottle (267478)

21 January 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GOLD CROSS MINOXIDIL EXTRA STRENGTH 5% w/v topical application bottle.
LD CROSS BIS-PECTIN oral liquid suspension bottle Cancelled under s30(1)(c) of the Act

1 February 2018

Cancellation by sponsor

Requested by Biotech Pharmaceuticals Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.